Hiperurisemia dan hipertensi di Puskesmas Wates, Kulon Progo

Nor Anita Ulfah; Hari Kusnanto; Cornelia Wahyu Danawati

doi:10.22146/bkm.12353

Hiperurisemia dan hipertensi di Puskesmas Wates, Kulon Progo

https://doi.org/10.22146/bkm.12353

Nor Anita Ulfah^(1*), Hari Kusnanto⁽²⁾, Cornelia Wahyu Danawati⁽³⁾

(1) Departemen Biostatistik, Epidemiologi dan Kesehatan Populasi, Fakultas Kedokteran, Universitas Gadjah Mada
(2) Departemen Biostatistik, Epidemiologi dan Kesehatan Populasi, Fakultas Kedokteran, Universitas Gadjah Mada
(3) Departemen Ilmu Penyakit Dalam, Fakultas Kedokteran, Universitas Gadjah Mada
(*) Corresponding Author

Abstract

Hyperuricemia and hypertension in Wates primary health care center

Purpose

The purpose of this paper was to determine the relationship between hyperuricemia and hypertension occurrence in Wates primary health care center.

Method

A cross-sectional study was conducted using medical records of 220 patients with the age of 18 years or older who met the inclusion criteria in Wates primary health care center in 2015.

Results

The study found that hyperuricemia was associated with hypertension occurrence in Wates primary health care center in 2015, while age and dyslipidemia were confounders in the hyperuricemia and hypertension relationship.

Conclusion

It was found that hyperuricemia had some influence on hypertension occurrence. There are many etiological factors associated with hypertension causing the difficulty of predicting the most common causes of hypertension. A cohort study should be done for further study. Early detection of elevated serum uric acid levels as a risk factor for hypertension needs to be done, in order to prevent hypertension.

Keywords

hypertension; hyperuricemic; Yogyakarta

Full Text:

PDF (Bahasa Indonesia)

References

WHO. Global Action Plan For The Prevention And Control of Noncommunicable Disease. Geneva, Switzerland.; 2013.
Badan Penelitian dan Pengembangan Kesehatan Departemen Kesehatan RI. Riset Kesehatan Dasar 2013. Jakarta; 2014.
Ferrannini E, Natali A. Essential hypertension, metabolic disorders, and insulin resistance. Am Heart J. 1991 Apr;121(4 Pt 2):1274–82.
Feig DI, Kang D-H, Johnson RJ. Uric Acid and Cardiovascular Risk. N Engl J Med. Massachusetts Medical Society; 2008 Oct 23;359(17):1811–21
Heinig M, Johnson RJ. Role of uric acid in hypertension, renal disease, and metabolic syndrome. Cleve Clin J Med. 2006 Dec;73(12):1059–64.
Iliesiu A, Campeanu A, Dusceac D. Serum uric acid and cardiovascular disease. Maedica (Buchar). Amaltea Medical, Editura Magister; 2010 Jul;5(3):186–92.
Poudel B, Yadav BK, Kumar A, Jha B, Raut KB. Serum uric acid level in newly diagnosed essential hypertension in a Nepalese population: a hospital based cross sectional study. Asian Pac J Trop Biomed. China Humanity Technology Publishing House; 2014 Jan;4(1):59–64.
Lee JE, Kim Y-G, Choi Y-H, Huh W, Kim DJ, Oh HY. Serum Uric Acid Is Associated With Microalbuminuria in Prehypertension. Hypertensi. 2006;47:963–7.
Leiba A, Vinker S, Dinour D, Holtzman EJ, Shani M. Uric acid levels within the normal range predict increased risk of hypertension: a cohort study. J Am Soc Hypertens. 2015 Aug;9(8):600–9.
Lippi G, Montagnana M, Franchini M, Favaloro EJ, Targher G. The paradoxical relationship between serum uric acid and cardiovascular disease. Clin Chim Acta. 2008 Jun;392(1–2):1–7.
Perlstein TS, Gumieniak O, Williams GH, Sparrow D, Vokonas PS, Gaziano M, Weiss ST, Litonjua AA. Uric acid and the development of hypertension. Hypertension. 2006 Dec 1;48(6):1031-6.